DK1625152T3 - Peptider, som modulerer sktiviteten af Engrailed-transskriptionsfaktoren - Google Patents
Peptider, som modulerer sktiviteten af Engrailed-transskriptionsfaktorenInfo
- Publication number
- DK1625152T3 DK1625152T3 DK04742777T DK04742777T DK1625152T3 DK 1625152 T3 DK1625152 T3 DK 1625152T3 DK 04742777 T DK04742777 T DK 04742777T DK 04742777 T DK04742777 T DK 04742777T DK 1625152 T3 DK1625152 T3 DK 1625152T3
- Authority
- DK
- Denmark
- Prior art keywords
- trp
- transcription factor
- activity
- ser
- peptides
- Prior art date
Links
- 230000000694 effects Effects 0.000 title abstract 4
- 102000040945 Transcription factor Human genes 0.000 title abstract 3
- 108091023040 Transcription factor Proteins 0.000 title abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
- 230000000648 anti-parkinson Effects 0.000 abstract 1
- 239000000939 antiparkinson agent Substances 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
- 230000000324 neuroprotective effect Effects 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Psychology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0306023A FR2855178B1 (fr) | 2003-05-20 | 2003-05-20 | Peptides modulateurs de l'activite du facteur de transcription engrailed |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1625152T3 true DK1625152T3 (da) | 2007-01-22 |
Family
ID=33396590
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04742777T DK1625152T3 (da) | 2003-05-20 | 2004-05-19 | Peptider, som modulerer sktiviteten af Engrailed-transskriptionsfaktoren |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20070155668A1 (da) |
| EP (1) | EP1625152B1 (da) |
| JP (1) | JP2007532093A (da) |
| AT (1) | ATE339441T1 (da) |
| CY (1) | CY1105846T1 (da) |
| DE (1) | DE602004002400T2 (da) |
| DK (1) | DK1625152T3 (da) |
| ES (1) | ES2273277T3 (da) |
| FR (1) | FR2855178B1 (da) |
| PL (1) | PL1625152T3 (da) |
| PT (1) | PT1625152E (da) |
| WO (1) | WO2004104030A2 (da) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2897780B1 (fr) * | 2006-02-28 | 2008-05-23 | Centre Nat Rech Scient | Utilisation de la proteine a homeodomaine engrailed comme anxiolytique |
| GB0803352D0 (en) | 2008-02-22 | 2008-04-02 | Ntnu Technology Transfer As | Oligopeptidic compounds and uses thereof |
| NZ592928A (en) * | 2008-11-24 | 2012-12-21 | Univ Ramot | Method for treating parkinson' s disease using filamentous bacteriophage |
| EP2454597A1 (en) * | 2009-07-13 | 2012-05-23 | The University of Surrey | Therapeutic peptides, polypeptides ans nucleic acid sequences |
| CN108289929A (zh) * | 2015-09-23 | 2018-07-17 | 国家科学研究中心 | 用于治疗神经退行性障碍的同源异型蛋白 |
| US12188042B2 (en) | 2018-07-09 | 2025-01-07 | NanoCav, LLC | Electroporation devices and methods of cell transfection |
| US12527950B2 (en) | 2018-07-09 | 2026-01-20 | NanoCav, LLC | Electroporation devices and methods of cell transfection |
| WO2020014264A1 (en) | 2018-07-09 | 2020-01-16 | NanoCav, LLC | Micro flow-through electroporation devices and methods of cell transfection |
-
2003
- 2003-05-20 FR FR0306023A patent/FR2855178B1/fr not_active Expired - Fee Related
-
2004
- 2004-05-19 DE DE602004002400T patent/DE602004002400T2/de not_active Expired - Fee Related
- 2004-05-19 US US10/557,239 patent/US20070155668A1/en not_active Abandoned
- 2004-05-19 ES ES04742777T patent/ES2273277T3/es not_active Expired - Lifetime
- 2004-05-19 DK DK04742777T patent/DK1625152T3/da active
- 2004-05-19 AT AT04742777T patent/ATE339441T1/de not_active IP Right Cessation
- 2004-05-19 EP EP04742777A patent/EP1625152B1/fr not_active Expired - Lifetime
- 2004-05-19 JP JP2006530368A patent/JP2007532093A/ja not_active Ceased
- 2004-05-19 WO PCT/FR2004/001233 patent/WO2004104030A2/fr not_active Ceased
- 2004-05-19 PL PL04742777T patent/PL1625152T3/pl unknown
- 2004-05-19 PT PT04742777T patent/PT1625152E/pt unknown
-
2006
- 2006-12-12 CY CY20061101790T patent/CY1105846T1/el unknown
-
2008
- 2008-09-08 US US12/206,207 patent/US20090131320A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20090131320A1 (en) | 2009-05-21 |
| CY1105846T1 (el) | 2011-02-02 |
| FR2855178A1 (fr) | 2004-11-26 |
| ATE339441T1 (de) | 2006-10-15 |
| DE602004002400T2 (de) | 2007-09-20 |
| PT1625152E (pt) | 2007-01-31 |
| WO2004104030A3 (fr) | 2005-02-10 |
| EP1625152B1 (fr) | 2006-09-13 |
| FR2855178B1 (fr) | 2005-08-05 |
| DE602004002400D1 (de) | 2006-10-26 |
| US20070155668A1 (en) | 2007-07-05 |
| EP1625152A2 (fr) | 2006-02-15 |
| ES2273277T3 (es) | 2007-05-01 |
| PL1625152T3 (pl) | 2007-04-30 |
| JP2007532093A (ja) | 2007-11-15 |
| WO2004104030A2 (fr) | 2004-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1111225T1 (el) | Νεα πεπτιδια ως αναστολεις πρωτεασης νs3-σερινης ιου ηπατiτιδας c | |
| DK1778297T3 (da) | Adenoassocieret viral vektor til exon-overspringning i et gen, som koder for et protein med overflödige domæner | |
| CR9452A (es) | Agentes terapeuticos a base de peptidos de toxinas | |
| MXPA04003333A (es) | Remodelado y glicoconjugacion de peptidos. | |
| NO20075693L (no) | Modulerende forbindelser av indolamin-2,3-dioksygenase og fremgangsmater for anvendelse av samme | |
| TR200200508T2 (tr) | Bisayklik androjen ve projesteron reseptörü modülatör bileşikleri ve metodları. | |
| CY1107294T1 (el) | Τοπικη συνθεση η οποια περιεχει τουλαχιστον μια βιταμινη d ή ενα αναλογο της βιταμινης d και τουλαχιστον ενα κορτικοστεροειδες | |
| ATE520390T1 (de) | Glycopyrrolat in kosmetischen zubereitungen | |
| UY28348A1 (es) | Compuestos novedosos | |
| DK1097173T3 (da) | Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler | |
| DK1625152T3 (da) | Peptider, som modulerer sktiviteten af Engrailed-transskriptionsfaktoren | |
| WO2004053059A3 (en) | Mitoneet polypeptide from mitochondrial membranes, modulators thereof, and methods of using the same | |
| ATE425180T1 (de) | Ein chimäres protein das nichttoxische pseudomonas exotoxin a und typ iv pilin sequenzen enthält | |
| BRPI0418229A (pt) | genes do ciclo celular e métodos corrrelatos de uso | |
| NO984344L (no) | Ny asymmetriske syntese av R-<alfa>-propylpiperonyalamin og dets analoger | |
| DE502004011395D1 (de) | Protein-bindende doxorubicin-peptid-derivate | |
| ATE451112T1 (de) | Oligopeptide enthaltende dermatologische zusammensetzungen zur steigerung der hautempfindlichkeit | |
| NO972313D0 (no) | Peptider som er i stand til å binde til GAP-protein-SH3-området, nukleotid-sekvenser som koder for dette samt fremstilling og bruk derav | |
| BRPI0506148A (pt) | preparação farmacêutica para o tratamento de choque | |
| SG165168A1 (en) | New adenoviruses, nucleic acids coding therefor and their use | |
| ATE385805T1 (de) | Neue peptide | |
| NO20031908L (no) | Polyanhydrider, fremgangsmate for fremstilling, anvendelse i begroingshindrende maling og begroingshindrende maling inneholdende polyanhydrider | |
| EA200700951A1 (ru) | БЕЛКИ, СОДЕРЖАЩИЕ ДОМЕНЫ vWFA И/ИЛИ ANT_IG | |
| ATE356867T1 (de) | Epitopen aus dem epha2-antigen | |
| ATE358136T1 (de) | Prionen-bindende peptidsequenzen |